-- ファクトセットが調査したアナリストによると、ラムリサーチ（LRCX）の平均投資判断は「オーバーウェイト」、平均目標株価は311.43ドルです。 （は、北米、アジア、ヨーロッパの主要銀行および調査会社による株式、商品、経済に関する調査レポートを配信しています。調査レポート提供者の方は、こちらからお問い合わせください：https://www..com/contact-us）
Price: $248.74, Change: $-2.50, Percent Change: -1.00%
Related Articles
Research
Research Alert: CFRA Downgrades Rating To Sell From Hold On Shares Of Essex Property Trust, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target by $15 to $250 using a narrower equity risk premium and a forward P/FFO of 15.5x, which is in line with the multifamily residential REIT average. We keep our 2026 FFO estimate at $16.15 and lower 2027's by $0.05 to $16.45 on respective revenue projections of $1.94B and $1.98B. Rental revenue is not yet rebounding to historical growth levels. Across the industry, we are seeing inflation in key operating expenses exceeding revenue growth, and this leads to modest gains in cash NOI growth Y/Y. We expect these market conditions to continue as pricing power for ESS and its peers seems to have eased. In particular, ESS has a West Coast portfolio profile that is exposed to significant job layoffs in the technology sector. In our opinion, we have not yet seen the tail risk of major announcements just released in recent weeks. ESS has the challenge of complying with strict housing guidelines in California, leading to the trust historically underperforming peers in other parts of the country.
$ESS
Research
Research Alert: CFRA Keeps Buy Rating On Shares Of Biogen Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our target at $236, 13.8x our new 2027 EPS view, a discount to BIIB's five-year historical forward P/E average of 14.1x. We lower our 2026 EPS view to $15.24 from $16.14 to adjust for the impact from acquired IPR&D. We keep our 2027 EPS view at $17.16. BIIB reported a strong start to 2026, with sales of $2.5B and adjusted EPS of $3.57. We see a successful stabilization of the business after years of decline, due to a 12% Y/Y increase in the growth products portfolio. In our view, during the analyst call, management presented a clear strategic vision centered on the pending $5.6B acquisition of Apellis, expected to close in Q2, which can transform BIIB into a growth company by adding two commercial assets, Syfovre and Empaveli. We think the Apellis deal could bridge a revenue gap until 2028, when the company's late-stage pipeline matures. Via this acquisition, BIIB also gains nephrology expertise and an established infrastructure, which could set its key asset Felzartamab launch for success.
$BIIB
Sectors
Update: WTI Oil Closes Above US$100 With No End to the Iran War in Sight; U.S. Inventories Fall
West Texas Intermediate (WTI) crude oil closed higher on Wednesday, rising for a fourth-straight session as hopes for a coming end to the Iran war and a reopening of the Strait of Hormuz fade, while a report showed an larger than expected drop in U.S. oil inventories.WTI crude oil for June delivery closed up US$6.95 to settle at US$106.88 per barrel, the highest since April 7, while June Brent oil was last seen up US$6.74 to US$118.00.WTI has now climbed 59% since the war began on Feb. 28, when Iran blocked the Strait of Hormuz, a key chokepoint for roughly 20% of global oil supply, following attacks by the United States and Israel. The United States is now blockading Iranian ports and Iran has demanded that be lifted before peace talks can resume, which the U.S. is refusing to do, continuing the largest-ever supply shock."The near closure of the Strait of Hormuz prolongs a disruption that continues to tighten global energy markets ... Traders now focus on the next steps in peace talks and today's US inventory report for further signs of how quickly US stockpiles are falling amid robust export demand," Saxo Bank wrote.In its weekly survey, the Energy Information Administration reported U.S. commercial oil inventories fell by 6.2-million barrels last week, while the consensus estimate among analysts polled by Reuters forecast a drop of 2.2-million barrels.The oil market is also focusing on the Tuesday decision by the United Arab Emirates to withdraw from the OPEC Cartel. The UAE is OPEC's third-largest producer and the No. 7 global oil exporter. The decision is unlikely to have a near-term effect, given the supply shock, but could add additional supply to the market once the conflict ends."Given the world is currently suffering from a lack of supply due to the closure of the Strait of Hormuz, the UAE's departure doesn't really matter since it is already producing at its maximum capacity. That is the maximum it can export via its pipeline (1.5-1.8 mb/d) to the Gulf of Oman given the closure of the Strait, which is why the UAE's overall output fell to 2.37 mb/d in March (vs. 3.64 mb/d in February). In the longer run, when hopefully the conflict is resolved, it may matter more as the UAE could supply the global oil market with an additional 1.0 mb/d. Moreover, OPEC/OPEC+ is losing one of its most vital members," Art Woo, a senior economist at BMO Capital Markets, wrote.
$CLM6$LCOM6$USO